九芝堂(000989.SZ):辰能創投擬將所持不超1738萬股參與轉融通證券出借業務
格隆匯12月28日丨九芝堂(000989.SZ)公佈,公司於2021年12月27日收到公司持股5%以上股東黑龍江辰能工大創業投資有限公司(“辰能創投”)《關於黑龍江辰能工大創業投資有限公司轉融通證券出借業務的吿知函》。
辰能創投為促進國有資產保值增值,盤活存量資產,將持有的部分公司流通股參與轉融通證券出借業務,計劃參與轉融通證券出借業務股份不超過1738萬股,即不超過公司總股本的2%,且在任意連續90個自然日內用作轉融通證券出借的公司股份不超過公司總股本的1%。參與期限為從2021年12月27日起後6個月內。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.